Epristeride

爱普列特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEpristeride
Drug Alias Name川流SKF-105657ONO-9302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 5 alpha reductase 2 inhibitors
TargetsSteroid 5 alpha reductase 2
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Lianhuan Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Lianhuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Hyperplasia
Inactive IndicationsN/A

Other Information

ATC CodeG04C
Related LinksWikipediaKEGG